These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background. Bresin E; Daina E; Noris M; Castelletti F; Stefanov R; Hill P; Goodship TH; Remuzzi G; Clin J Am Soc Nephrol; 2006 Jan; 1(1):88-99. PubMed ID: 17699195 [TBL] [Abstract][Full Text] [Related]
5. Atypical hemolytic uremic syndrome: update on the complement system and what is new. Hirt-Minkowski P; Dickenmann M; Schifferli JA Nephron Clin Pract; 2010; 114(4):c219-35. PubMed ID: 20090363 [TBL] [Abstract][Full Text] [Related]
16. The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts. Fremeaux-Bacchi V; Kemp EJ; Goodship JA; Dragon-Durey MA; Strain L; Loirat C; Deng HW; Goodship TH J Med Genet; 2005 Nov; 42(11):852-6. PubMed ID: 15784724 [TBL] [Abstract][Full Text] [Related]
17. The role of defective complement control in hemolytic uremic syndrome. Zipfel PF; Misselwitz J; Licht C; Skerka C Semin Thromb Hemost; 2006 Mar; 32(2):146-54. PubMed ID: 16575689 [TBL] [Abstract][Full Text] [Related]
18. Hemolytic uremic syndrome: an example of insufficient complement regulation on self-tissue. Atkinson JP; Liszewski MK; Richards A; Kavanagh D; Moulton EA Ann N Y Acad Sci; 2005 Nov; 1056():144-52. PubMed ID: 16387683 [TBL] [Abstract][Full Text] [Related]